Determine MTD and to Evaluate pk, Safety/Tolerability and Efficacy Profiles of Hocena® in NSCLC Subjects
Clinical trial NCT01134016 · COMPLETED
Trial details
- NCT number
- NCT01134016
- Sponsor
- Golden Biotechnology Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2013-06-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.